Abstract
BackgroundAfter the introduction of biologics for the treatment of patients with active rheumatoid arthritis (RA), clinical remission has become an achievable and realistic therapeutic goal. In clinical trials, remission rates...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have